Healthcare -
Biotechnology - NASDAQ - US
$ 6.96
0 %
$ 476 M
Market Cap
-1.21
P/E
PHAT - SHORT-TERM DEBT
Short-term Debt PHAT - Phathom Pharmaceuticals, Inc.
726 K
LAST VALUE
-13.66%
2 YEAR CAGR
-17.93%
5 YEAR CAGR
0.00%
10 YEAR CAGR